These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38563454)

  • 1. Oral anticoagulants and antiplatelet treatment in different settings.
    Eur Heart J Cardiovasc Pharmacother; 2024 May; 10(3):171-172. PubMed ID: 38563454
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual antiplatelet and oral anticoagulant therapy: increasing use and precautions for a hazardous combination.
    Hylek EM; Solarz DE
    JACC Cardiovasc Interv; 2008 Feb; 1(1):62-4. PubMed ID: 19393146
    [No Abstract]   [Full Text] [Related]  

  • 3. Focus on pharma in acute coronary syndrome.
    Agewall S
    Eur Heart J Cardiovasc Pharmacother; 2020 Jan; 6(1):1-2. PubMed ID: 31909430
    [No Abstract]   [Full Text] [Related]  

  • 4. Management issues of chronic therapy with non-vitamin K oral anticoagulants or antiplatelet agents: Different or alike?
    Rossini R; Capodanno D; Ferrero P; Gargiulo G; Capranzano P
    Int J Cardiol; 2016 Oct; 221():695-6. PubMed ID: 27423092
    [No Abstract]   [Full Text] [Related]  

  • 5. What's new in antiplatelet and anticoagulant therapy recommendations for unstable angina/non-ST-elevation myocardial infarction: 2012 focused update from the American College of Cardiology Foundation/American Heart Association task force on practice guidelines.
    Wenger NK;
    Clin Cardiol; 2012 Nov; 35(11):669-72. PubMed ID: 23070718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: is clopidogrel any safer than aspirin when combined with warfarin?
    Tay KH; Lane DA; Lip GY
    Thromb Haemost; 2008 Dec; 100(6):955-7. PubMed ID: 19132214
    [No Abstract]   [Full Text] [Related]  

  • 7. Dual antiplatelet therapy plus oral anticoagulation: how does hemorrhagic risk impact stent selection?
    Giugliano GR; Lotfi AS
    JACC Cardiovasc Interv; 2008 Jun; 1(3):330; author reply 330-1. PubMed ID: 19463324
    [No Abstract]   [Full Text] [Related]  

  • 8. New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis.
    Oldgren J; Wallentin L; Alexander JH; James S; Jönelid B; Steg G; Sundström J
    Eur Heart J; 2013 Jun; 34(22):1670-80. PubMed ID: 23470494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticoagulants and antiplatelet agents in pregnancy].
    Tsakiris DA
    Ther Umsch; 2005 Jan; 62(1):23-7. PubMed ID: 15702703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Benefits and Risks of Oral Antiplatelet Therapy in Patients with Acute Coronary Syndrome.
    Ahmad T; Davies R; Alagona P
    J Fam Pract; 2017 Feb; 66(2 Suppl):. PubMed ID: 29095443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges of antiplatelet therapy in patients who require anticoagulation.
    Henkel DM; Holmes DR
    J Invasive Cardiol; 2009 Apr; 21(4):186-9. PubMed ID: 19342758
    [No Abstract]   [Full Text] [Related]  

  • 12. Return of Oral Anticoagulation in Chronic Stable Coronary Disease.
    Verheugt FWA
    Circulation; 2018 Apr; 137(16):1655-1657. PubMed ID: 29661947
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intracerebral hemorrhage caused by oral anticoagulant, oral antiplatelet and intravenous tissue plasminogen activator therapy].
    Yoshida Y
    Nihon Rinsho; 2006 Nov; 64 Suppl 8():531-4. PubMed ID: 17469605
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardiovascular diseases, antiplatelet agents, anticoagulants and hemorrhagic risk].
    Eusébio J; Reny JL; Fontana P; Nendaz M
    Rev Med Suisse; 2010 Oct; 6(267):1942, 1944-6, 1948-50. PubMed ID: 21125726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conundrums in the combined use of anticoagulants and antiplatelet drugs.
    Schneider DJ; Sobel BE
    Circulation; 2007 Jul; 116(3):305-15. PubMed ID: 17638939
    [No Abstract]   [Full Text] [Related]  

  • 16. Glycoprotein inhibitors in patients on chronic anticoagulation: safe enough or too much risk?
    Marín F; Bonacasa B; Valdés M
    Thromb Haemost; 2010 Jan; 103(1):11-2. PubMed ID: 20062940
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy].
    Nowak-Göttl U; Langer F; Limperger V; Mesters R; Trappe RU
    Dtsch Med Wochenschr; 2014 Jun; 139(24):1301-6. PubMed ID: 24892468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenge of coprescription of antiplatelet therapy and oral anticoagulants.
    Jolobe OMP
    Am J Emerg Med; 2017 Nov; 35(11):1782-1783. PubMed ID: 28579296
    [No Abstract]   [Full Text] [Related]  

  • 19. [Platelet inhibitor and oral anticoagulants. Discontinue antithrombotic drugs before colonoscopy?].
    Stiefelhagen P
    MMW Fortschr Med; 2014 Sep; 156(15):22. PubMed ID: 25282925
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral anticoagulation alone or in combination with aspirin: risks and benefits.
    Hafner J; de Moerloose P; Bounameaux H
    Vasa; 1996; 25(1):1-12. PubMed ID: 8851260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.